Clinical Trial News Archive
Get news by email or subscribe to our news feeds.
News Archive for November 2008
November 3, 2008
- CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma
- Antiangiogenic Role of 2ME2 Demonstrated in Rheumatoid Arthritis Models
- Medarex and Massachusetts Biologic Laboratories Announce Primary Objective Achieved in Phase 2 Trial of Monoclonal Antibody Combination for the Treatment of Clostridium difficile Associated Diarrhea (CDAD)
- Oncolytics Biotech Inc. Collaborators Present Positive Combination and Docetaxel Results at iSBTc Annual Meeting
- Oncolytics Biotech Inc. Collaborators Present Positive Phase I/II Combination Reolysin and Paclitaxel/Carboplatin Results at iSBTc Annual Meeting
- CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma
- Cell Therapeutics Announces Study Data Set Cut-off for Phase III Pivotal Pixantrone (301) Trial
- Boceprevir Phase II Study Showed High Rate of Sustained Response With 28- and 48-Week Regimens in Genotype 1 Treatment-Naive Hepatitis C Patients
- Romark Announces Presentation of New Data for Nitazoxanide in Chronic Hepatitis C at AASLD 2008
- Gilead Announces Two-Year Data from Pivotal Phase III Studies Evaluating Viread(R) for Chronic Hepatitis B
- GlobeImmune Hepatitis C Therapeutic Vaccine, GI-5005
- Study Suggests Treatment with Paliperidone ER Significantly Improves Symptoms of Schizoaffective Disorder
- Avineuro Announced Advancing Potent Small Molecule for Treatment of Alzheimer's Disease to Clinical Development
- New Study Demonstrated Actemra (tocilizumab) Inhibited Progression of Joint Damage in Rheumatoid Arthritis Patients
- Top-Line Preliminary Data From Phase II/III Study of Corthera's Relaxin in Acute Heart Failure to be Presented in Satellite Symposium at AHA Scientific Sessions 2008
- Medgenics Announces Encouraging Preliminary Data For Phase I/II Clinical Trial of EPODURE In Renal Anemia
- New Clinical Data Support Broad Profile for Telaprevir in Patients with Genotype 1 Hepatitis C Virus (HCV) Infection
- Anti-VEGF Drugs for Retinal Diseases Could Have Serious Side Effects, Scientists Caution
- Anadys Pharmaceuticals Announces Single Dose Safety and Pharmacokinetics Results for ANA598 in Healthy Volunteers
- Durezol in the Treatment of Uveitis and Ganciclovir in the Treatment of Herpetic Keratitis: Studies of Treatments for Leading Causes of Blindness to Be Presented
- PAREXEL Expert to Address Key Aspects of Conducting Clinical Trials in China at 7th Annual Partnerships in Clinical Trials Congress
- New Data Suggest Long-Term Treatment with Baraclude (entecavir) May Reduce Liver Damage Caused by Chronic Hepatitis B
November 4, 2008
- NicOx announces favorable blood pressure data for naproxcinod in a large ABPM study
- Phase IIa data on TMC435350 in patients with hepatitis C now presented at the ongoing AASLD
- ZymoGenetics Presents Positive Interim Phase 1b Results in Hepatitis C
- Vertex announces positive data at the annual AASLD meeting
- YM Biosciences Reports Data From Exploratory Clinical Trials Of Nimotuzumab In Brain Metastases And High-Grade Glioma Presented At 2008 Eortc-Nci-Aacr Annual Meeting
- Oramed Pharmaceuticals Chosen to Present Results of GLP-1 Analog Enteral Administration Study at the Diabetes Technology Society's Eighth Annual Meeting (November 13-15, 2008; Bethesda, Maryland)
- AMA Journal Publishes Study Showing Evidence of a Major Environmental Trigger For Autism
- Micromet Presents Data at the 23rd Annual Meeting of the International Society for Biological Therapy of Cancer on the Activity of Human Antibody Adecatumumab against KRAS-mutated Colon Cancer Cells
- PRA International Addresses Sponsor-CRO Partnering Strategies at European Partnerships in Clinical Trials Congress
- Generex Oral-lyn Featured at International Diabetes Conference
- Premier Research Achieves Double-Digit Growth in Functional Sourcing for the Third Straight Year
- NicOx Announces Favorable Blood Pressure Data for Naproxcinod in a Large ABPM Study
November 5, 2008
- Kendle Reports Record 3Q 08 Net Income and Total Business Authorizations
- Ambrx to Present Phase I/II Clinical Data for Optimized, Long Acting Human Growth Hormone Analogue
- SciClone and Sigma-Tau Report Phase 3 Hepatitis C Trial Results
- AgilityBio and Advinus Announce Partnership to Introduce Digital Pathology Services in Pre Clinical Research
- Centre Hospitalier Universitaire Vaudois, Swiss Vaccine Research Institute and Institut Genetique Moleculaire Montpellier: Study Sheds Light on the Mechanisms of Increased Risk of HIV Infection in the Step HIV Vaccine Trial
- Five Synexus Sites Randomise More Than 1300 Patients in Three Weeks
- Bio-Imaging Technologies Announces Third Quarter 2008 Financial Results
- Zannos Grekos, MD to Present Clinical Results of Regenerative Stem Cell Treatments to the Dubai Congress on Anti-Aging and Aesthetic Medicine
November 6, 2008
- PAREXEL Expands Pioneering Asian Ethnobridging Expertise
- Bavarian Nordic reports successful safety data from Phase II study with Imvamune
- Azilect Shown to Be a Selective MAO-B Inhibitor
- Canopus BioPharma Announces Positive Results in Human Study of Novel Peptide Cancer Vaccine
- Living Cell Technologies Reports on 12-Month Clinical Effects of DiabeCell at Annual General Meeting
- Dendreon Presents Integrated Analysis of Clinical Data from Neuvenge Trials at Chemotherapy Foundation Symposium
- Portola Announces Data Presentations Relevant to Its Lead Phase II Antithrombotic Compounds at American Heart Association Scientific Sessions 2008
- Webcast Alert: Isis Pharmaceuticals' Cardiovascular Program Review
- Data to Be Presented at 58th Annual Meeting of The American Society of Human Genetics
- Aegerion Pharmaceuticals, Inc. Announces AEGR-733 Phase II Data Demonstrates Significant Lowering of LDL Cholesterol with Promising Hepatic Safety Profile
- Sunesis Pharmaceuticals Presents Clinical Trial Data of Voreloxin in Patients with Acute Myeloid Leukemia and Ovarian Cancer at the Chemotherapy Foundation Symposium
- VIA Pharmaceuticals Announces Conference Call and Webcast to Discuss VIA-2291 Phase 2 Data Presentations at AHA
- Proteon Therapeutics Presents New Data on PRT-201 at the Annual Meeting of the American Society of Nephrology in Philadelphia
- Pervasis Therapeutics Presents Safety Data from Phase 1 and 2 Clinical Trials of Vascugel at the American Society of Nephrology Annual Meeting
- Morria Biopharmaceuticals Plc Announces Positive Clinical Results for MRX-4 in its Phase II Clinical Study in Allergic Rhinitis Patients
- Affymax Announces New Data Presented on the Long-Term Safety and Effectiveness of Hematide to Treat Anemia in Chronic Renal Failure Patients with Monthly Dosing
- Acologix Presents Findings From the UREMIC PRURITIS National Registry Study at the 41st Annual Meeting of the American Society of Nephrology
- Poniard Pharmaceuticals Announces Final Top-Line Results from Phase 1 Trial Demonstrating Positive Bioavailability with Oral Picoplatin
- Oncolytics Biotech Inc. Investigators Present Interim U.S. Reolysin Phase II Sarcoma Trial Data
- Cytochroma Announces Positive Comparative Data on CTA018 in Chronic Kidney Disease Model
- Study From the University of Texas M.D. Anderson Cancer Center Demonstrates That AHC is Safe in Combination With Most Chemotherapeutic Agents
- DW Healthcare Partners Forms Best in Class Organization with ClinPro Inc. and Pacific Data Designs, LLC
- LSR Announces Third Quarter Results
November 7, 2008
- Full Results of Varisolve US Phase II Safety Study to be Presented at ACP
- Phase III Study (SATURN) Showed Tarceva Improved Progression-Free Survival as a First-Line Maintenance Therapy for Advanced Non-Small Cell Lung Cancer
- Cytochroma Announces Positive Comparative Data on CTA018
- Kendle Named a 'Best Place to Work' in Greater Cincinnati
- Sciele Pharma and Plethora Solutions Announce Positive Phase III Clinical Results of PSD502 for Premature Ejaculation
- Acologix AC-200 Demonstrates Positive Effect on Bone in Preclinical Model of Chronic Kidney Disease
- Pervasis Therapeutics Presents Data at American Society of Nephrology Meeting
- Atrial Fibrillation Found to be Common in Patients With Atherothrombosis, Increases Risk of Cardiovascular Death, Heart Attack and Stroke
- Theratechnologies Presents Additional Results from its Tesamorelin Phase 3 Studies at the 10th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV
- Rationale and Design of CURRENT-OASIS 7 Study Published in American Heart Journal
- Data From Investigational Use of Procrit (Epoetin alfa) Presented at American Society of Nephrology Annual Meeting
- iCo Therapeutics Oral Amphotericin B Effective Against Visceral Leishmaniasis
- Santhera Presents Preclinical Data on Oral MC4 Receptor Antagonists for Treatment of Cancer Cachexia at AICR Research Conference
November 10, 2008
- Aradigm Completes Study of Inhaled Treprostinil with AERx Inhaler
- Memory Pharmaceuticals Announces Six Abstracts Accepted for Presentation at Society for Neuroscience Meeting
- Zevalin Following Short-Course Chemotherapy with CHOP + Rituximab (CHOP-R) Doubles Complete Remission Rate in First-Line Treatment of Follicular Non- Hodgkin's Lymphoma
- EKC-Cide Study Results Presented at National Ophthalmology Meeting
- Geron Scientists and Collaborators Demonstrate TAT2 - A Small Molecule Telomerase Activator - Enhances Antiviral Function of Immune Cells From HIV+ Donors
- VIA Pharmaceuticals Announces Positive Results of Phase 2 Studies of VIA-2291 in Patients With Serious Cardiovascular Disease
- First-Ever Study Conducted Demonstrating Economic, Individual, and Societal Burden of Hereditary Angioedema
- EntreMed's MKC-1 Meets Primary Efficacy Endpoint in Non-Small Cell Lung Cancer Clinical Trial
- Molecular Insight Pharmaceuticals, Inc. To Present Results from a Prospective Analysis of Zemiva Phase 2b Data at the 2008 Scientific Sessions of the American Heart Association
- Study Showed Prevention of Heart Attacks Within Three Months After Hospitalization Significantly Averted Future Heart Attacks and Death
- ProtoKinetix Receives Independent Confirmation of AAGP Anti-Inflammatory Action
- Study Shows Potential Benefits of Xolair in Treating Children Suffering from Moderate or Severe Persistent Allergic Asthma Inadequately Controlled With Inhaled Corticosteroids
- Glaucoma Research and Patient Care Highlighted at American Academy of Ophthalmology Meeting
- New Analysis Shows Troubling Trend in Triglyceride Levels May Be Linked to Rising Rates of Obesity
- Celladon Announces Presentation of Clinical Data From First-in-Human Mydicar Trial for Advanced Heart Failure at American Heart Association Scientific Sessions
- The Results From a Clinical Trial Led by the Montreal Heart Institute Demonstrate That Drug Reduces Inflammation in Patients With Serious Cardiovascular Disease
- UCLA Medical Researchers Report Brain Injury After Cardiac Arrest May Be Avoided
- Crestor Demonstrates Dramatic CV Risk Reduction in a Large Statin Outcomes Study
- Results of Studies of Alvesco for the Treatment of Asthma and Omnaris in an HFA Nasal Aerosol Presented at American College of Allergy, Asthma & Immunology Annual Meeting
- Molecular Insight Announces Positive Results from a Prospective Analysis of Phase 2b Data for Zemiva in Emergency Department Setting
- Research Identifies Predictors for Successful IVF
- Interim Analysis of Top-Line Data From Phase II/III Study Shows Favorable Efficacy & Safety for Corthera's Relaxin in Acute Heart Failure
- Keryx Biopharmaceuticals' KRX-0401 (Perifosine) Data Selected for Oral Presentation at the 50th Annual Meeting of the American Society of Hematology
- Rivaroxaban Phase II Dose-Ranging Study Demonstrates Encouraging Response Rates in Treatment of Acute Coronary Syndrome Patients
- Largest Study Demonstrates Comparable Pregnancy Outcomes Using Vaginal Gel versus Injectable Progesterone, with Frozen Embryos from Donor Eggs
- Santaris Pharma Releases Positive Data on LNA-based Survivin Inhibitor
- Four Pralatrexate (PDX) Studies to Be Presented at the 50th Annual Meeting of the American Society of Hematology
- Potentia Pharmaceuticals' Drug Candidate for Age-Related Macular Degeneration Shows Positive Safety Profile in Phase I Clinical Trial
- Genmab A/S: Ofatumumab Pivotal CLL Data to be Presented at ASH
- RVX-208 Exploratory Study Illustrates Early Potential for Alzheimer's Disease
- Ofatumumab Pivotal CLL Data to be Presented at ASH
November 11, 2008
- Intestinal Infection Afflicts 13 of 1,000 Hospital Patients, Infection Rates 6.5 - 20 Times Greater Than Previous Estimates, New Study Says
- RVX-208 Data Demonstrates Increase in Functional HDL Particles
- Researchers to Present Additional Data on Soliris (eculizumab) for the Treatment of PNH at the ASH Annual Meeting
- Cell Therapeutics' Pixantrone Phase III (EXTEND) Pivotal Trial Successful in Achieving Primary Endpoint
- PARI Pharma Completes Successful Clinical Trials for Tobramycin 100 & Investigational eFlow for CF
- NEI Releases Complete Data From Age-Related Eye Disease Study
- FibroGen Announces New Research on HIF-PHI and Anti-CTGF Development Programs in Chronic Kidney Disease
- Sangamo BioSciences Announces Results From Diabetic Neuropathy Clinical Trial SB-509-601
- Rigel's R788 Phase 2a Results Published in Arthritis and Rheumatism
- Potentia Presents Phase I Data on Leading AMD Drug at AAO
- WomenHeart Urges Women to Talk With Doctors About New Study Showing Statins Prevent Heart Attacks, Deaths
- Anesiva Announces Adlea ACTIVE-1 Phase 3 Clinical Results, Ceasing of Zingo Commercial Operations and Restructuring
- CPEX Pharmaceuticals Announces Publication in Journal of Diabetes Science and Technology
- Optimer Pharmaceuticals Reports Positive Data from its North American Phase 3 CDI Study of OPT-80
- Anthera's Varespladib Demonstrates Significant Anti-Inflammatory Effect and LDL Reduction in Patients With Coronary Heart Disease
- INNO-406 Demonstrates Positive Clinical Responses in Phase 1 Trial in Patients with Chronic Myeloid Leukemia
- Triglyceride Levels Continue to Rise in the United States Despite Increased Use of Cholesterol-Lowering Medications
- LCP-AtorFen Phase II Data to Be Presented at the American Heart Association's 2008 Scientific Sessions in New Orleans, LA, on November 11
- New Research of Amyloid Cardiomyopathy Fosters Better Understanding of Disease Progression
- Lipocine Establishes Clinical Feasibility of Once-a-Day Ziprasidone
- Testosterone Effective in Female Sexual Dysfunction; BioSante Conducting Long-Term Safety Study of LibiGel in FSD
- IMM, Cenix, and Alnylam Discover New Targets in Malaria Infection with RNAi Technology
- Published Study Demonstrates Oxycyte Can Improve Cognitive Recovery And Reduce Neuronal Cell Loss After Traumatic Brain Injury in Animal Model
- Raptor Pharmaceuticals Corp. Announces Positive Phase IIa Clinical Study Results for Convivia Program
- Colesevelam HCl Lowered LDL Cholesterol in Pediatric Patients With Heterozygous Familial Hypercholesterolemia
- Drug-Eluting Stents Beat Bare Metal Stents in Diabetics
- Dronedarone (Multaq) Reduced the Incidence and Duration of Hospitalization in Patients with Atrial Fibrillation
- Statin Reduces Heart Attack, Stroke Rates in Patients With Normal Cholesterol but Elevated C-Reactive Protein
- Tailored Drug Delivery Reduces Adverse Effects After PCI
- Study Finds Timing Is Everything For Some Heart Attack Patients
- Phase II Trial of Experimental Anti-Coagulant Reports Safety and Outcomes Data
- Heart Failure Patients With Normal Left Ventricular Ejection Fraction Don't Benefit From Treatment With Angiotensin II Receptor Blocker
- POZEN'S PA32520 Study Data Demonstrated Better Upper Gastrointestinal Protection
- Interferon Reduces, Eliminates Viral Infections in Heart Failure Patients
- MD Biosciences to Showcase Pre-Clinical Capabilities at the Neuroscience 2008 Conference
- New study: A Common Class of GI Medications Reduce Protection Against Heart Attack in Patients Taking Widely Prescribed Cardiovascular Drug
- APIC Covers Up Extent and Causes of Deadly C. diff
- Colesevelam HCl Lowered LDL Cholesterol in Pediatric Patients with Heterozygous Familial Hypercholesterolemia
- Rasilez, first-in-class direct renin inhibitor, provides greater reduction in high blood pressure than ACE inhibitor ramipril in patients 65 and older
- Study Demonstrating Lovaza/Omacor Co-administered with Atorvastatin Reduces Non-HDL Cholesterol to be presented at AHA
November 12, 2008
- Acusphere Announces Data Demonstrating Imagify Perfusion Stress Echo Predicts Presence of Coronary Artery Disease
- American Academy of Ophthalmology Joint Meeting Marked by Strong Turnout and Rich Scientific Program
- NicOx' Naproxcinod Shows Highly Significant Reduction in Daytime Blood Pressure Versus Naproxen
- Titan Pharmaceuticals Announces Data Presentations for Probuphine at the 2008 International Society of Addiction Medicine Congress
- Pervasis Therapeutics to Present Safety and Efficacy Data from Phase 1 and 2 Clinical Trials of Vascugel(R) at the 35th Annual VEITHsymposium(TM)
- Metabolex Announces Positive Results From Phase 1a Clinical Trial of MBX-2982
- ImmunoCellular Therapeutics Presents Data Demonstrating Immune Response Targeting Cancer Stem Cells
- SCOLR Pharma, Inc. to Attend American Association of Pharmaceutical Scientists - AAPS - Annual Meeting and Exposition
- Portola Announces Data Showing Its Anti-Platelet Drug Inhibits Platelets in Clopidogrel (Plavix) Non-Responders
- New Analysis Suggests That Improvements in Kidney Function in Patients Treated with Lipitor Strongly Correlate with a Reduced Risk of Major Cardiovascular Events
- Nymox Reports Positive New Results in 59 Week Study of Drug for Enlarged Prostate
- Tercica Announces Results from Increlex Phase IIIb Study Demonstrating Dose-Dependent Height Velocity Increase in Primary IGFD Short Stature Population and Other Increlex Studies at the 13th International Congress of Endocrinology Meeting
- Ongoing Pregnancy Rates among Infertility Patients with Luteal Phase Bleeding No Different with Vaginal Gel or Injectable Progesterone
- Benign or Cancerous?
- Tibotec Data Presented at ICAAC and HIV9 Follow key Regulatory Approvals for Anti-HIV Compounds
- Nymox Reports Positive New Results in 59 Week Study of Drug for Enlarged Prostate
- Long-term study evaluates boosted Prezista vs. lopinavir/ritonavir as part of HIV combination therapy in treatment-naive adults
November 13, 2008
- MorphoSys Publishes Preclinical Data from MOR103 Program
- Lexicon's Drug Candidate LX1032 for Carcinoid Syndrome Successfully Completes Phase 1 Clinical Trials
- Osteoporosis Drugs May Prevent Future Bone Growth
- Gardasil, Merck's Cervical Cancer Vaccine, Demonstrated Efficacy in Preventing HPV-Related Disease in Males in Phase III Study
- Avexa Presents Data from Apricitabine and Antibacterial Programs at two International Conferences
- Micromet to Present Interim Data from Two Studies for T Cell Engaging BiTE Antibody Blinatumomab at American Society of Hematology Annual Meeting
- Gardasil, Merck's Cervical Cancer Vaccine, Demonstrated Efficacy in Preventing HPV-Related Disease in Males in Phase III Study
- Clinical Data Show Long-Acting Human Growth Hormone ARX201 is Safe and Well Tolerated
- Scientists Crack the Code to Tamoxifen Resistance
- Seniors Can Be Heartened by New Study on Statins
- Preclinical Study Presented at the International Congress of Endocrinology Shows Intravail Drug Delivery Technology Provides Unmatched Non-Invasive Delivery of an Anti-Obesity Peptide
- Merck KGaA: Overall Survival in First-Line NSCLC Reaches 15 Months
- ViroPharma Announces Presentation of Cinryze Data in Acute Treatment of Hereditary Angioedema
- BioReliance Corporation Announces that Sarah Sheridan, Ph.D. Will Deliver a Poster Presentation at the 16th Annual European Society of Gene and Cell Therapy Conference
- Avastin Gives an Additional Four Months of Life to Patients with One of the Most Common Types of Lung Cancer
November 14, 2008
- ThromboGenics Announces Promising Six Month Follow-Up Results from its Phase IIb Trial of Microplasmin (MIVI III) for Treatment of Visual Disorders
- Oncolytics Biotech Inc. Collaborators to Present Reolysin Research at CTOS Annual Meeting
- Oxford BioMedica Announces Two Scientific Presentations of ProSavin in Parkinson's Disease
- Oramed Pharmaceuticals Presents Results of Oral Administration of Exenatide-4; Proof of Concept Pharmacodynamic Study in Dogs
- New Data Points to Long Lasting Beneficial Effects of CEL-SCI's Rheumatoid Arthritis Vaccine
November 17, 2008
- FREEDOM-C Trial of Oral Treprostinil in Pulmonary Arterial Hypertension Fails to Meet Primary Endpoint
- Alkermes Presents Positive Preclinical Data on Novel, ProprietaryMolecule Designed to Improve Outcomes for Patients Taking OpioidAnalgesics
- Medivation Announces Upcoming Data Presentations on Dimebon's Mechanism of Action
- Paloma Pharmaceuticals Publishing Seminal Paper in Cancer Research and Presentation at the AACR Special Conference in Cancer Research
- Sequella Presents Data on Synergy Between Investigational New TB Drugs SQ109 and TMC207
- Patients Experienced Nearly a 70% Reduction in Pain When Using MPMMedical's Regenecare Wound Care Gel
- ZIOPHARM Oncology Presents Positive Data from Studies of Palifosfamide
- Hepatitis C Therapeutic DNA Vaccine Delivered by Inovio Biomedical's Electroporation Technology Reduces Viral Load by Up to 99.7%
- Biodel Reports Protective Effects of VIAject Insulin on Microvascular Function in Patients with Type 2 Diabetes
- ARYx Therapeutics Presents Clinical Data for ATI-5923 at American Heart Association Scientific Sessions 2008
November 18, 2008
- Long-Term TITAN Study Evaluates Prezista/ritonavir vs. lopinavir/ritonavir as Part of HIV Combination Therapy in Treatment-Experienced Adults
- Company's MPACs for the Treatment of Alzheimer's Disease Shown to Prevent Neural Cell Death and the Production of Amyloid-Beta Protein
- Cimzia (certolizumab pegol) Studies Show Significant Clinical Benefits for Mono- and Combination Therapy in Patients with Rheumatoid Arthritis
- Study Published In Archives Of Surgery Demonstrated Benefit Of Entereg (Alvimopan) In Postoperative Ileus
- Metabolex Announces Positive Results from Phase 2 Clinical Trial of MBX-8025
- XTL Biopharmaceuticals Announces Top-Line Results From the Bicifadine Phase 2b Study for Diabetic Neuropathic Pain
- New Publication Shows Angiomax Significantly Reduces Initial Hospital Costs by $572 Per Patient Compared to Conventional Therapy in Moderateand High-Risk ACS Patients
- New Data Will Be Presented at ASH on Velcade (Bortezomib) for Injection-Based Therapies in Multiple Myeloma and Non-Hodgkin's Lymphoma
- Research Provides Further Evidence for the Mechanism of Action Underlying Hythiam’s Prometa Treatment Program
- Provectus Lead Investigator Professor John F. Thompson to Present at Clinical Oncological Society of Australia 2008 Annual Scientific Meeting on November 19, 2008
November 19, 2008
- Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting
- Elixir Pharmaceuticals’ Phase III Trial of Metformin-Mitiglinide Combination Therapy Demonstrates Significant Reductions in HbA1c (Blood Glucose) Levels Compared to Type 2 Diabetes Patients Not Well-Controlled on Metformin Alone
- GenVec Announces Interim Survival Data in Pivotal Trial of TNFerade in Locally Advanced Pancreatic Cancer
- Titan Pharmaceuticals Presents Phase 3 Data for Probuphine at the 2008 International Society of Addiction Medicine Congress
- Jazz Pharmaceuticals Cancels Presentation Planned for November 19, 2008 at Lazard Capital Markets 5th Annual Healthcare Conference
- Pervasis Therapeutics Announces Promising Efficacy Results from Phase1 and 2 Clinical Trials of Vascugel® in Dialysis Patients Needing Permanent AV Access, Data Builds on Compelling Safety Findings
- New Study Proves Protandim Produces 300% Increase in Glutathione, a Key Antioxidant and Anti-aging Factor
- Helix BioPharma Presents Preclinical L-DOS47 Data at The Second Conference of Lung Cancer in Warsaw, Poland
- Suven Life Sciences Presenting Biology Data of Their NCE’s at Society for Neuroscience Annual Meeting, SFN-2008 at Washington DC, USA
- Phase III Studies Show That Vandetanib (Zactima) Brings Clinical Benefits to Patients With Lung Cancer
- Bradmer to Present Poster on Progression Free Survival and Overall Survival Data from Neuradiab Phase II Trials at Society for Neuro-Oncology Meeting
- Oxford BioMedica Announces Six-Month Efficacy Results With Low Dose of ProSavin in Phase I/II Trial in Parkinson’s Disease
- Genfit New Phase I Clinical Trials with High-Dose Confirm the Excellent Tolerance of GFT505 in Healthy Volunteers
- KAI Reports Positive Preclinical Results for KAI-1678, First-in-ClassCompound to Treat Pain
- Pharmos Announces Clinical Results from Phase 2a Trial of Topical Diclofenac NanoEmulsion Cream
November 20, 2008
- Lytix Presents LTX-109 Anti-Microbial Data at ICAAC
- Alnylam Presents Pre-clinical Data from TTR Amyloidosis Development Program
- Targacept Scientists Make Multiple Presentations at Society for Neuroscience Supporting the Potential of NNR Therapeutics to Treat CNSDiseases and Disorders
- Provectus Lead Investigator Professor John F. Thompson Gives Update on PV-10 Melanoma Study at Clinical Oncological Society of Australia 2008 Annual Scientific Meeting
- Gloucester Pharmaceuticals to Present Positive Results from Multiple Romidepsin Clinical Trials at the ASH Annual Meeting
- Thought Leaders from Burzynski Research Institute, Inc. Present Encouraging Data on Antineoplastons for Treatment of Malignant Gliomas
- Biovitrum and Symphogen Report Positive Clinical Results in Novel Rh-immunization Prevention Project
- Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology
November 21, 2008
- Rexin-G Controls Tumor Growth and Improves Survival in Chemotherapy-Resistant Soft Tissue Sarcoma and Osteosarcoma: Phase I/II & Confirmatory Phase II Studies
- Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia
- New Study Data: Januvia (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes
- Burzynski Research Institute, Inc. (BRI) Presents Promising Phase II Data on Malignant Glioma
- Iressa Proves Just as Effective as Chemotherapy for Lung Cancer Findings Represent First Time Oral Therapy Tested Head-to-Head Against Standard Therapy; Surprising Biomarker Results
- Study shows GE Healthcare's Visipaque Associated with Lower Incidence of Contrast-Induced Nephropathy and Cardiovascular Events in Patients with Chronic Kidney Disease Compared to Iopromide
- Transgene’s TG1042 meets primary end point in step one of cutaneous B-cell lymphoma Phase II trial
November 24, 2008
- Bioniche Presents MCC Data at the SIU World Uro-Oncology Update in Santiago, Chile
- Final Data From Phase 1 Investigator-Sponsored Trial of Oncophage Cancer Vaccine in Glioma Presented
- ARIAD to Present Preclinical Data on Multi-Targeted Kinase Inhibitor at 50th Ash Annual Meeting
- Third Pivotal Phase 3 Study for NicOx' Naproxcinod Shows Positive Efficacy, Safety and Blood Pressure Results
- Data Published in Nature Medicine Highlights Ability of Peregrine Pharmaceuticals' Bavituximab to Cure Lethal Virus Infections
- Valeant Reports Encouraging End of Treatment Results with Taribavirin at Treatment Week 48 in Phase IIb Study
- ProtoKinetix Receives Independent Confirmation of AAGP Anti-Inflammatory Action
- Largest-ever studies on most common form of adult leukemia, show patients treated with MabThera live longer without disease progressing
- Testosterone Effective in Female Sexual Dysfunction; BioSante Conducting Long-Term Safety Study of LibiGel in FSD
- Peregrine's Anti-Viral Bavituximab in Nature Medicine
- Avastin Plus Commonly Used Chemotherapies Demonstrated Improved Progression-Free Survival in Advanced Breast Cancer
- New Cancer Treatment Shrinks Pancreatic Tumor
- Schering-Plough Reports Preladenant Meets Primary Endpoint in Phase II Dose-Finding Trial for Parkinson's Disease
- Labopharm to Host Webcast Presentation on Novel Trazodone Formulation for Treatment of Major Depressive Disorder
- Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C
- Schering-Plough Unveils Top-Line Study Results for SAPHRIS (asenapine) Demonstrating Efficacy in Long-Term Schizophrenia Relapse Prevention
- Protox announces positive Phase 2 BPH results
November 25, 2008
- Proteolix to Present Clinical and Preclinical Data at the 50th Annual Meeting of the American Society of Hematology
- ERYtech Pharma Presents a New Advance in the Treatment of Sickle Cell Anaemia
- Aegera Therapeutics' Phase 1/2 Clinical Trial Results Selected for Oral Presentation at 2008 ASH Annual Meeting
- Telcagepant Proven as a Safe and Effective Migraine Treatment in Phase III Trial
- Press Release: Rexin-G Controls Tumor Growth and Improves Survival in Chemotherapy-Resistant Soft Tissue
November 26, 2008
- Stanford/Packard Study Shows No Benefit From Drug Widely Used to Prevent Premature Births
- Wyeth and Progenics Announce Positive Outcome of Phase 3 Clinical Study of Subcutaneous Relistor for Opioid-Induced Constipation in Patients with Chronic Non-Cancer Pain
- Ceregene Announces Clinical Data From Phase 2 Clinical Trial of CERE-120 for Parkinson's Disease
- Growth hormone not beneficial for ALS
- Flamel Technologies Update
- Study Compares Strategies for BK Virus Nephropathy
- Nitric Oxide Can Alter Brain Function
